ClinicalTrials.Veeva

Menu

Impact of COVID-19 Pandemic on Headache Evaluations in the Pediatric Emergency Department

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Completed

Conditions

COVID-19
Headache Disorders
Emergency Service, Hospital

Study type

Observational

Funder types

Other

Identifiers

NCT06295003
CEFA-COVID

Details and patient eligibility

About

Background: To evaluate the impact of COVID-19 on evaluations in the pediatric emergency department (ED) because of headache as main symptom.

Methods: Number and clinical features of patients evaluated in the pediatric ED of a single site in Milan,Italy, were collected between January 2017 and January 2022. The impact of COVID-19 on evaluation rates was quantified by using the incidence rate ratio (IRR) and 95% confidence intervals (CI) between the pandemic (March 2020 to January 2022) and the prepandemic period (January 2017 to February 2020).

Enrollment

700 patients

Sex

All

Ages

2 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • range of age: 2 - 18 years
  • sex: all
  • headache as main symptom

Exclusion criteria

  • headache in the context of head trauma, because of different diagnostic-care in Pediatric Emergency Department

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems